chronic – media

Mallinckrodt inks $1.2B Sucampo buy, ending rough 2017 on a high note

Mallinckrodt, which has landed in hot water multiple times this year, is diversifying beyond its controversial lead seller.
- Source: fiercepharma
- 444
- December 28, 2017
chronic Company Insight constipation Market Views
Boehringer bags first biosimilar approval in the EU

Boehringer Ingelheim has won its first biosimilar approval in Europe with authorisation of Cyltezo for a range of chronic inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
- Source: Pharmatimes
- 601
- November 16, 2017
arthritis biosimilar chronic Cyltezo New Approvals
Study reveals how a very low calorie diet can reverse type 2 diabetes

In a new study, a Yale-led research team uncovers how a very low calorie diet can rapidly reverse type 2 diabetes in animal models. If confirmed in people, the insight provides potential new drug targets for treating this common chronic disease, said the researchers.
- Source: Medicalxpress
- 547
- November 14, 2017
calorie chronic diabetes Researches
A Chinese Province Is Sequencing One Million of Its Residents’ Genomes

Authorities in the city of Nanjing, the capital of China’s Jiangsu province, announced at the end of October that they would sequence the genes of 1 million individuals to build a genetic database of Chinese residents. This project is part of the National Health and Medicine Big Data Nanjing Center, a new data storage facility under construction in the region.
- Source: futurism
- 598
- November 10, 2017
cancer chronic gene Market Views sequence
Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim

Dicerna Pharmaceuticals and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases. Dicerna can get up to $201 million in upfront and success-based development and commercialization milestones for an undisclosed target.
- Source: biospace
- 552
- November 3, 2017
chronic liver diseases Market Views RNAi
Medtronic secures FDA approval for Intellis spinal cord stimulator

Medtronic has secured the US Food and Drug Administration (FDA) approval for its next generation spinal cord stimulator branded as Intellis platform for the management of certain forms of chronic intractable pain.
- Source: medicaldevices-business-review
- 1,009
- September 21, 2017
chronic Company Insight spinal cord stimulator
FDA grants fast-track designation for Shire’s lung drug

The FDA has granted Fast Track designation to Shire's SHP607 for the prevention of chronic lung disease in extremely premature infants.
- Source: Pharmatimes
- 589
- September 14, 2017
chronic Clinical lung New Approvals
AstraZeneca announces new mRNA collaboration

A five-year strategic research collaboration between AstraZeneca and its global biologics research and development arm MedImmune and Ethris, a company focussed on mRNA-based therapeutics with specific expertise in pulmonary disease.
- Source: pharmatimes
- 822
- August 22, 2017
asthma chronic collaboration Company Insight mRNA therapy
New study examines potential Alzheimer’s disease prevention strategies

The future of researching ways to prevent AD should probably focus on people at risk for developing the disease, said researchers, and should highlight how to improve management of chronic health conditions and education about living healthier.
- Source: news-medical
- 495
- August 10, 2017
Alzheimer's chronic Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.